Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr 22;24(1):166.
doi: 10.1186/s13054-020-02878-7.

IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome

Etienne Dufranc  1 , Arnaud Del Bello  1   2 , Julie Belliere  1   3   4 , Nassim Kamar  1   2   3 , Stanislas Faguer  5   6   7 ; TAIDI (Toulouse Acquired Immune Deficiency and Infection) study group
Collaborators, Affiliations
Comment

IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome

Etienne Dufranc et al. Crit Care. .
No abstract available

Keywords: HLH; Hemophagocytic lymphohistiocytosis; IL-6; Tocilizumab.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
Ferritin concentration after tocilizumab
See this image and copyright information in PMC

Comment on

  • Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.
    La Rosée P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, Birndt S, Gil-Herrera J, Girschikofsky M, Jordan MB, Kumar A, van Laar JAM, Lachmann G, Nichols KE, Ramanan AV, Wang Y, Wang Z, Janka G, Henter JI. La Rosée P, et al. Blood. 2019 Jun 6;133(23):2465-2477. doi: 10.1182/blood.2018894618. Epub 2019 Apr 16. Blood. 2019. PMID: 30992265

References

    1. La Rosée P, Horne AC, Hines M, Greenwood TVB, Machowicz R, Berliner N, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood Ame Soc Hematol. 2019;133:2465–2477. - PubMed
    1. Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66:2613–2620. doi: 10.1002/art.38690. - DOI - PubMed
    1. Fitzgerald JC, Weiss SL, Maude SL, Barrett DM, Lacey SF, Melenhorst JJ, et al. Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia. Crit Care Med. 2017;45:e124–e125. doi: 10.1097/CCM.0000000000002053. - DOI - PMC - PubMed
    1. Faguer S, Vergez F, Peres M, Ferrandiz I, Casemayou A, Belliere J, et al. Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis. Hematol Oncol. 2016;34(1):55–7. - PubMed
    1. Ahmed A, Merrill SA, Alsawah F, Bockenstedt P, Campagnaro E, Devata S, et al. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. Lancet Haematol. 2019;6:e630–e637. doi: 10.1016/S2352-3026(19)30156-5. - DOI - PMC - PubMed